INTERNATIONAL SOCIETY OF OCULAR ONCOLOGY CO KRYSTAL CROWE (EIN 593788740) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Phone

9202032587

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL SOCIETY OF OCULAR ONCOLOGY CO KRYSTAL CROWE, founded in 2004, is a small nonprofit in the Community Improvement sector that reported $348K in total revenue in fiscal year 2024. Revenue surged 153% from the prior year, signaling strong growth momentum. The organization ran a surplus of $182K, a strong 52% operating margin.

Mission

THE PRIMARY PURPOSE OF THE ENTITY IS TO ADVANCE AND PROMOTE THE PRACTICE OF OCULAR ONCOLOGY BY COORDINATING WITH GENERAL OPTHAMOLOGY, ONCOLOGY, PATHOLOGY AND ALLIED SCIENCES BY THE ENCOURAGEMENT OF RESEARCH, BY THE IMPROVEMENT OF TEACHING, TECHNICAL METHODS AND PATIENT CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $326,275

Program Service Revenue $0

Investment Income $21,458

Other Revenue $0

TOTAL REVENUE $347,733

Expense Breakdown

Grants Paid $27,774

Salaries & Benefits $38,392

Fundraising Expenses $0

Program Expenses $107,209

Other Expenses $99,650

TOTAL EXPENSES $165,816

Year-over-Year Comparison

	2024	2023	Change
Revenue	$347,733	$137,595	+1.5%
Expenses	$165,816	$87,010	+0.9%
Net Income	$181,917	$50,585	+2.6%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$3,500

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SANDRA DAILY	Director	4.00	Officer	$3,500	$0	$3,500
DAN GOMBOS MD	Director	0.00	Officer Director	$0	$0	$0
JESSE BERRY MD	Director	0.00	Officer Director	$0	$0	$0
BHAVNA CHAWLA MD	Director	0.00	Officer Director	$0	$0	$0
VICTORIA VISHNEVKSKIA DAI MD	Director	0.00	Officer Director	$0	$0	$0
KATHERINE PATON MD	Director	0.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$347,733	$165,816	$645,896	$181,917
2023	$137,595	$87,010	$410,529	$50,585
2022	$159,097	$115,574	$359,944	$43,523
2021	$67,857	$70,104	$316,422	$-2,247
2020	$46,673	$20,422	$318,668	$26,251
2019	$116,011	$90,236	$292,417	$25,775
2018	$57,545	$10,269	$266,642	$47,276

INTERNATIONAL SOCIETY OF OCULAR ONCOLOGY CO KRYSTAL CROWE